O
CERS icon

OrbiMed’s Cerus CERS Stock Holding History

OrbiMed’s Portfolio CERS Stock Details CERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-578,300
Closed -$3.43M – 139
2016
Q1 		$3.43M Sell
578,300
-5,926,100
-91% -$32.8M 0.04% 123
2015
Q4 		$41.1M Hold
6,504,400
– – 0.37% 57
2015
Q3 		$29.5M Sell
6,504,400
-1,803,327
-22% -$9.33M 0.3% 60
2015
Q2 		$43.1M Hold
8,307,727
– – 0.36% 57
2015
Q1 		$34.6M Buy
8,307,727
+1,272,727
+18% +$6.52M 0.3% 64
2014
Q4 		$43.9M Sell
7,035,000
-150,000
-2% -$681K 0.42% 54
2014
Q3 		$28.8M Buy
7,185,000
+2,947,000
+70% +$11.3M 0.3% 59
2014
Q2 		$17.6M Hold
4,238,000
– – 0.21% 67
2014
Q1 		$20.3M Buy
4,238,000
+863,000
+26% +$5.55M 0.25% 65
2013
Q4 		$21.8M Buy
3,375,000
+817,100
+32% +$5.13M 0.32% 61
2013
Q3 		$17.2M Buy
+2,557,900
New +$13.9M 0.31% 60

Other funds holding CERS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

OrbiMed's CERS Position: Q2 2016 in Review

OrbiMed sold out of Cerus (CERS) in Q2 2016, closing a stake of 578,300 shares — an estimated $3.43M sold.

OrbiMed first reported a position in CERS in Q3 2013 and held it in 11 quarters. The position peaked at $43.9M in Q4 2014. 131 funds tracked by Wall St. Rank hold CERS as of Q2 2016.

  • OrbiMed reported no remaining Cerus position as of Q2 2016 after selling out during the quarter.
  • OrbiMed sold 578,300 Cerus shares in Q2 2016, an estimated $3.43M.
  • OrbiMed first reported a position in Cerus in Q3 2013 and held it in 11 quarters.
  • OrbiMed's Cerus position peaked at $43.9M in Q4 2014.
  • 131 funds tracked by Wall St. Rank held Cerus as of Q2 2016.

Based on OrbiMed's 13F filing for Q2 2016, filed 15 Aug 2016.